Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

KLF4, p21 and context-dependent opposing forces in cancer.

Rowland BD, Peeper DS.

Nat Rev Cancer. 2006 Jan;6(1):11-23. Review.

PMID:
16372018
2.

Lost in transcription: p21 repression, mechanisms, and consequences.

Gartel AL, Radhakrishnan SK.

Cancer Res. 2005 May 15;65(10):3980-5. Review.

3.

TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer.

Ellenrieder V.

Anticancer Res. 2008 May-Jun;28(3A):1531-9. Review.

4.

Emerging role of KLF4 in human gastrointestinal cancer.

Wei D, Kanai M, Huang S, Xie K.

Carcinogenesis. 2006 Jan;27(1):23-31. Epub 2005 Oct 11. Review.

PMID:
16219632
5.

p21(WAF1/CIP1) and cancer: a shifting paradigm?

Gartel AL.

Biofactors. 2009 Mar-Apr;35(2):161-4. doi: 10.1002/biof.26. Review.

PMID:
19449443
6.

Disruption of oncogene/tumor suppressor networks during human carcinogenesis.

Münger K.

Cancer Invest. 2002;20(1):71-81. Review.

PMID:
11853005
7.

p21WAF1 and tumourigenesis: 20 years after.

Warfel NA, El-Deiry WS.

Curr Opin Oncol. 2013 Jan;25(1):52-8. doi: 10.1097/CCO.0b013e32835b639e. Review.

PMID:
23159848
8.

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

Radtke F, Raj K.

Nat Rev Cancer. 2003 Oct;3(10):756-67. Review.

PMID:
14570040
9.

Oncogenes, cancer and imaging.

Urbain JL.

J Nucl Med. 1999 Mar;40(3):498-504. Review.

10.

Biological actions of oncogenes.

Smith MR, Matthews NT, Jones KA, Kung HF.

Pharmacol Ther. 1993;58(2):211-36. Review.

PMID:
8415879
11.

The role of KLF6 and its splice variants in cancer therapy.

DiFeo A, Martignetti JA, Narla G.

Drug Resist Updat. 2009 Feb-Apr;12(1-2):1-7. doi: 10.1016/j.drup.2008.11.001. Epub 2008 Dec 18. Review.

PMID:
19097929
12.

Vascular implications of the Krüppel-like family of transcription factors.

Suzuki T, Aizawa K, Matsumura T, Nagai R.

Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1135-41. Epub 2005 Apr 7. Review.

13.

The double life of KLF5: Opposing roles in regulation of gene-expression, cellular function, and transformation.

Diakiw SM, D'Andrea RJ, Brown AL.

IUBMB Life. 2013 Dec;65(12):999-1011. doi: 10.1002/iub.1233. Epub 2013 Dec 10. Review.

14.

The RUNX genes: gain or loss of function in cancer.

Blyth K, Cameron ER, Neil JC.

Nat Rev Cancer. 2005 May;5(5):376-87. Review.

PMID:
15864279
15.

Oncogenes and growth factors--an updating.

Ernberg IT.

Eur J Surg Suppl. 1991 May;(561):15-20. Review. No abstract available.

PMID:
1720043
16.

Krüppel-like factors in cancer.

Tetreault MP, Yang Y, Katz JP.

Nat Rev Cancer. 2013 Oct;13(10):701-13. doi: 10.1038/nrc3582. Review.

PMID:
24060862
17.
18.

Malignancy: an evolving definition of a cancer cell.

Williams JL.

Clin Lab Sci. 2002 Winter;15(1):37-43. Review. No abstract available.

PMID:
12778955
19.

Loss of cancer suppressors, a driving force in carcinogenesis.

Bouck NP, Benton BK.

Chem Res Toxicol. 1989 Jan-Feb;2(1):1-11. Review. No abstract available.

PMID:
2519224
20.

[Oncogenes, tumor suppression genes and medical genetics of cancer].

Bootsma AH, Cornelisse CJ, de Klein A.

Ned Tijdschr Geneeskd. 1992 May 23;136(21):1009-13. Review. Dutch. No abstract available.

PMID:
1318508

Supplemental Content

Support Center